Soleno Therapeutics Inc’s recent filing unveils that its Rule 144 Affiliate Abingworth Bioventures VII LP acquired Company’s shares for reported $51.42 million on Oct 21 ’24. In the deal valued at $54.16 per share,949,336 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Abingworth Bioventures VII LP bought 2,522,751 shares, generating $125,204,132 in total proceeds.
Before that, Yen Kristen sold 3,108 shares. Soleno Therapeutics Inc shares valued at $153,627 were divested by the insider at a price of $49.43 per share. As a result of the transaction, Yen Kristen now holds 81,465 shares, worth roughly $3.9 million.
Stifel reiterated its Soleno Therapeutics Inc [SLNO] rating to a Buy in a research note published on December 02, 2024; the price target was $74. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who remained covering the stock and in early December has reiterated a ‘”an Outperform”‘ rating for it. H.C. Wainwright began covering SLNO with “Buy” recommendation on September 03, 2024. Robert W. Baird started covering the stock on May 10, 2024. It rated SLNO as “an Outperform”.
Price Performance Review of SLNO
On Monday, Soleno Therapeutics Inc [NASDAQ:SLNO] saw its stock jump 2.61% to $47.93. Over the last five days, the stock has gained 0.02%. Soleno Therapeutics Inc shares have risen nearly 19.08% since the year began. Nevertheless, the stocks have risen 28.91% over the past one year. While a 52-week high of $60.92 was reached on 11/25/24, a 52-week low of $35.04 was recorded on 01/04/24. SMA at 50 days reached $53.26, while 200 days put it at $47.14.
Levels Of Support And Resistance For SLNO Stock
The 24-hour chart illustrates a support level at 46.91, which if violated will result in even more drops to 45.89. On the upside, there is a resistance level at 48.86. A further resistance level may holdings at 49.79. The Relative Strength Index (RSI) on the 14-day chart is 38.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.09, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 79.53%. Stochastics %K at 11.03% indicates the stock is a buying.
How much short interest is there in Soleno Therapeutics Inc?
A steep rise in short interest was recorded in Soleno Therapeutics Inc stocks on 2024-11-29, dropping by -1.61 million shares to a total of 4.56 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 6.17 million shares. There was a decline of -35.45%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 05, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $93 price target.
